✦ LIBER ✦

MHC Class II-Transfected Tumor Cells Induce Long-Term Tumor-Specific Immunity in Autologous Mice

✍ Scribed by Sivasubramanian Baskar; Viola Azarenko; Elizabeth Garcia Marshall; Eric Hughes; Suzanne Ostrand-Rosenberg

Book ID: 112238947
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 420 KB
Volume: 155
Category: Article
ISSN: 0008-8749
DOI: 10.1006/cimm.1994.1106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor-specific immunity can be enhanced

Tumor-specific immunity can be enhanced by transfection of tumor cells with syngeneic MHC-class-II genes or allogeneic MHC-class-I genes

✍ S. Ostrand-Rosenberg; C. Roby; V. K. Clements; G. A. Cole 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 675 KB

Mouse Sal sarcoma cells are lethal in the autologous A/J (K") host. In order t o improve the immune response t o the Sal tumor, Sal cells have been transfected with syngeneic MHC-class-ll or allogeneic MHC-class4 genes. MHC-class-ll transfectants are uniformly rejected by the autologous host and imm

GFP-transfected tumor cells are useful i

GFP-transfected tumor cells are useful in examining early metastasisin vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice

✍ Markus Steinbauer; Markus Guba; Grigore Cernaianu; Gudrun Köhl; Michaela Cetto; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 275 KB

Autolymphocyte Therapy: II. Dependence o

Autolymphocyte Therapy: II. Dependence of in Vivo Anti-tumor Specificity and Long-Term Immunity against Murine Melanoma and Carcinoma on ex Vivo Activated Donor Memory T-Cells

✍ Jay E. Gold; Michael E. Osband 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 486 KB

Cell-mediated immunity to Moloney sarcom

Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors

✍ R. M. Gorczynski; R. A. Knight 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 814 KB

## Abstract Sublethally irradiated BALB/c mice innoculated with Moloney sarcoma virus (MSV‐M) develop progressively growing tumors and die within 30 days of virus innoculation. These animals can be protected from tumor progression (and death) by innoculation of small numbers of MSV‐immune T lymphoc